Tumor microenvironment changes leading to resistance of immune checkpoint inhibitors in metastatic melanoma and strategies to overcome resistance
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference64 articles.
1. Cancer statistics;Siegel;CA. Cancer J. Clin.,2015
2. Completely regressed cutaneous melanocytic lesion revisited;McCardle;Semin. Oncol.,2009
3. Clinical experience with ipilimumab 3mg/kg: real-world efficacy and safety data from an expanded access programme cohort;Ascierto;J. Transl. Med.,2014
4. Principles and use of anti-CTLA4 antibody in human cancer immunotherapy;Peggs;Curr. Opin. Immunol.,2006
5. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N. Engl. J. Med.,2010
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advancements and Challenges in Personalized Therapy for BRAF-Mutant Melanoma: A Comprehensive Review;Journal of Clinical Medicine;2024-09-12
2. Bioresponsive nanocomplex integrating cancer-associated fibroblast deactivation and immunogenic chemotherapy for rebuilding immune-excluded tumors;Nanomedicine: Nanotechnology, Biology and Medicine;2024-06
3. Microcystin-LR improves anti-tumor efficacy of oxaliplatin through induction of M1 macrophage polarization;Toxicon;2024-05
4. Unlocking PD‐1 antibody resistance: The MUC1 DNA vaccine augments CD8+ T cell infiltration and attenuates tumour suppression;Scandinavian Journal of Immunology;2024-01-19
5. Mendelian randomization analysis identified serum palmitoylcarnitine as a biomarker for hepatocellular carcinoma;2024-01-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3